scaht logo
SCAHT logo
EN DE FR
Toxicologie Réglementaire
Recherche SCAHT logo
Direction du SCAHT SCAHT logo
ISTNET-DART
PARC
CHIASMA
ONTOX
Financement de la recherche
Éducation SCAHT logo
SCAHT AOP_HUB
Publications
News SCAHT logo
Events
Newsletter / Lettre d'information
Agency News Corner
Ressources SCAHT logo
Links and Tools
Actualités sur les politiques mondiales
Équipe
INSCRIPTION À LA NEWSLETTER

En cas de suspicion d'empoisonnement, contactez Tox Info Suisse

Numéro d'urgence 24h tél. 145

(depuis l'étranger : +41 44 251 51 51)

Contact Confidentialité et mentions légales
EN DE FR
Toxicologie Réglementaire
Recherche SCAHT logo
Direction du SCAHT SCAHT logo
ISTNET-DART
PARC
CHIASMA
ONTOX
Financement de la recherche
Éducation SCAHT logo
SCAHT AOP_HUB
Publications
News SCAHT logo
Events
Newsletter / Lettre d'information
Agency News Corner
Ressources SCAHT logo
Links and Tools
Actualités sur les politiques mondiales
Équipe
INSCRIPTION À LA NEWSLETTER

En cas de suspicion d'empoisonnement, contactez Tox Info Suisse

Numéro d'urgence 24h tél. 145

(depuis l'étranger : +41 44 251 51 51)

Contact Confidentialité et mentions légales

8 Mar 2011

Quantification of glucuronidated and sulfated steroids in human urine by ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometry.

5 Mar 2011

Immune pathomechanism of drug hypersensitivity reactions.

5 Mar 2011

Highlights of the 4th Drug Hypersensitivity Meeting--Rome, April 22-25, 2010. Preface.

1 Mar 2011

Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis.

24 Fév 2011

Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity.

23 Fév 2011

In vitro diagnosis of T cell-mediated drug allergy.

22 Fév 2011

Intact protein analysis in the biopharmaceutical field.

4 Fév 2011

Formulation changes and time trends in outcome following paraquat ingestion in Sri Lanka.

18 Jan 2011

Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2.

12 Jan 2011

Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.

  • «
  • …
  • 47
  • 48
  • 49
  • 50
  • 51 (current)
  • 52
  • 53
  • 54
  • 55
  • …
  • »
logo scaht
logo université de genève
logo université de lausanne
logo fhnw
SCAHT newsletter subscriptions
* indicates required
Please select at least one newsletter

Please select all the ways you would like to hear from SCAHT - Swiss Centre for Applied Human Toxicology / University of Basel:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.